Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP706253.RAdOtSxUtkADZUs61H-uzN_94oXwx3V6AjUkQpRyGlMfY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP706253.RAdOtSxUtkADZUs61H-uzN_94oXwx3V6AjUkQpRyGlMfY130_assertion type Assertion NP706253.RAdOtSxUtkADZUs61H-uzN_94oXwx3V6AjUkQpRyGlMfY130_head.
- NP706253.RAdOtSxUtkADZUs61H-uzN_94oXwx3V6AjUkQpRyGlMfY130_assertion wasGeneratedBy ECO_0000203 NP706253.RAdOtSxUtkADZUs61H-uzN_94oXwx3V6AjUkQpRyGlMfY130_provenance.
- NP706253.RAdOtSxUtkADZUs61H-uzN_94oXwx3V6AjUkQpRyGlMfY130_assertion wasDerivedFrom befree-20140225 NP706253.RAdOtSxUtkADZUs61H-uzN_94oXwx3V6AjUkQpRyGlMfY130_provenance.
- NP706253.RAdOtSxUtkADZUs61H-uzN_94oXwx3V6AjUkQpRyGlMfY130_assertion SIO_000772 17878251 NP706253.RAdOtSxUtkADZUs61H-uzN_94oXwx3V6AjUkQpRyGlMfY130_provenance.
- NP706253.RAdOtSxUtkADZUs61H-uzN_94oXwx3V6AjUkQpRyGlMfY130_assertion evidence source_evidence_literature NP706253.RAdOtSxUtkADZUs61H-uzN_94oXwx3V6AjUkQpRyGlMfY130_provenance.
- NP706253.RAdOtSxUtkADZUs61H-uzN_94oXwx3V6AjUkQpRyGlMfY130_assertion description "[The objective of the investigation was to study the efficacy of a MEK1/2 inhibitor in thyroid cancer preclinical models with defined BRAF mutation status.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP706253.RAdOtSxUtkADZUs61H-uzN_94oXwx3V6AjUkQpRyGlMfY130_provenance.